These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2229050)

  • 1. Growth inhibition by vaccinia virus growth factor.
    Lin YZ; Ke XH; Tam JP
    J Biol Chem; 1990 Nov; 265(31):18884-90. PubMed ID: 2229050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity study of myxoma virus growth factor.
    Lin YZ; Ke XH; Tam JP
    Biochemistry; 1991 Apr; 30(13):3310-4. PubMed ID: 2009268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine phosphorylation of phospholipase C-gamma 1 by vaccinia virus growth factor.
    Kim HS; Lee YH; Min DS; Chang JS; Ryu SH; Ahn BY; Suh PG
    Virology; 1995 Dec; 214(1):21-8. PubMed ID: 8525617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and properties of cholecystokinin-releasing peptide (monitor peptide), a 61-residue trypsin inhibitor.
    Lin YZ; Isaac DD; Tam JP
    Int J Pept Protein Res; 1990 Nov; 36(5):433-9. PubMed ID: 2276871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of the vaccinia virus growth factor gene reduces virus virulence.
    Buller RM; Chakrabarti S; Cooper JA; Twardzik DR; Moss B
    J Virol; 1988 Mar; 62(3):866-74. PubMed ID: 3339716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical synthesis and biological activities of the EGF-like domain of mouse schwannoma-derived growth factor (SDGF).
    Takenouchi T; Kadosaka M; Shin SY; Munekata E
    Int J Pept Protein Res; 1995 Nov; 46(5):391-6. PubMed ID: 8567183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccinia growth factor: newest member of the family of growth modulators which utilize the membrane receptor for EGF.
    Twardzik DR; Ranchalis JE; Moss B; Todaro GJ
    Acta Neurochir Suppl (Wien); 1987; 41():104-9. PubMed ID: 3502224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of biological activity of synthetic fragments of transforming growth factor alpha.
    Schultz G; Twardzik D
    Methods Enzymol; 1991; 198():200-13. PubMed ID: 1857219
    [No Abstract]   [Full Text] [Related]  

  • 9. Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury.
    Marikovsky M; Breuing K; Liu PY; Eriksson E; Higashiyama S; Farber P; Abraham J; Klagsbrun M
    Proc Natl Acad Sci U S A; 1993 May; 90(9):3889-93. PubMed ID: 8483908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor occupancy inhibits vaccinia virus infection.
    Eppstein DA; Marsh YV; Schreiber AB; Newman SR; Todaro GJ; Nestor JJ
    Nature; 1985 Dec 19-1986 Jan 1; 318(6047):663-5. PubMed ID: 3001528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human betacellulin. Molecular structure, biological activities, and receptor interaction.
    Watanabe T; Shintani A; Nakata M; Shing Y; Folkman J; Igarashi K; Sasada R
    J Biol Chem; 1994 Apr; 269(13):9966-73. PubMed ID: 8144591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccinia virus-infected cells release a novel polypeptide functionally related to transforming and epidermal growth factors.
    Twardzik DR; Brown JP; Ranchalis JE; Todaro GJ; Moss B
    Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5300-4. PubMed ID: 3875097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological actions of the epidermal growth factors-like domain peptides of mouse schwannoma-derived growth factor and human amphiregulin.
    Takenouchi T; Kadosaka M; Shin SY; Munekata E
    J Pept Res; 1999 Feb; 53(2):120-5. PubMed ID: 10195449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell proliferative response to vaccinia virus is mediated by VGF.
    Buller RM; Chakrabarti S; Moss B; Fredrickson T
    Virology; 1988 May; 164(1):182-92. PubMed ID: 3363864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epidermal growth factor ortholog of ectromelia virus activates EGFR/ErbB1 and demonstrates mitogenic function in vitro.
    Morgis RA; Haan K; Schrey JM; Zimmerman RM; Hersperger AR
    Virology; 2021 Dec; 564():1-12. PubMed ID: 34560573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF.
    Higashiyama S; Abraham JA; Miller J; Fiddes JC; Klagsbrun M
    Science; 1991 Feb; 251(4996):936-9. PubMed ID: 1840698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the transforming growth factor beta-like activity of synthetic polypeptides comprising the amino-terminal sequence of human parathyroid hormone-related peptide.
    Kikuchi H; Shigeno C; Lee K; Ohta S; Shiomi K; Ikeda T; Sone T; Dokoh S; Konishi J
    Endocrinology; 1991 Mar; 128(3):1229-37. PubMed ID: 1999144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological activity of N-terminal-truncated derivatives of human epidermal growth factor (h-EGF).
    Shin SY; Shimizu M; Ohtaki T; Munekata E
    Peptides; 1995; 16(2):205-10. PubMed ID: 7784250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competition of a growth stimulating-/cholecystokinin (CCK) releasing-peptide (monitor peptide) with epidermal growth factor for binding to 3T3 fibroblasts.
    Fukuoka S; Fushiki T; Kitagawa Y; Sugimoto E; Iwai K
    Biochem Biophys Res Commun; 1987 Jun; 145(2):646-50. PubMed ID: 3496093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of epidermal growth factor, transforming growth factor-alpha, and vaccinia virus growth factor in the positive regulation of IFN-gamma production.
    Abdullah NA; Torres BA; Basu M; Johnson HM
    J Immunol; 1989 Jul; 143(1):113-7. PubMed ID: 2499624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.